Home » NH Angle

May 16. 2013 1:50PM

Manchester-based Boston Therapeutics posts wider net loss for quarter

The Company had a net loss of $667,422, or ($0.04) per share, for the quarter ended March 31, 2013 compared with a net loss of $257,405 or ($0.02) for the same period in the prior year. The Company's cash balance at March 31, 2013 was $384,674.

CLICK TO VIEW THE SOURCE MATERIAL

 New Hampshire Events Calendar
  

   » SHARE EVENTS FOR PUBLICATION, IT'S FREE!

Arts and Entertainment
Family, Community and Culture
Outdoors, Sports and Recreation